Home

Investment Cannabis

Globally, cannabis production and research has grown significantly in the recent years. The anticipated market is estimated to be over 300 billion dollars by 2022. Australia offers great opportunities in research and development of medicinal cannabis as a treatment for arthritis, cancer, common pain, epilepsy, glaucoma, nausea and vomiting and post-traumatic stress (PTSD), multiple sclerosis and Crohn's Disease. 

Medicinal Organic Cannabis Australia (MOCA) is poised to lead on the way. 

Cannabis is out of tune with this paradigm in multiple ways. For example, it is a medicine pioneered and promoted by patients and their caregivers, instead of scientific researchers or physicians. It is often consumed in its herbal form, using unconventional modes of intake such as smoking, vaporizing, tea or brownies. Moreover, cannabis may be used to treat difficult symptoms and improve quality of life for the chronically ill, but it also serves as a recreational drug that affects the minds of millions. This situation is further complicated by a continuously growing attention for cannabis by the media worldwide. As a result, patients, physicians, regulators and scientists may find it hard to understand what is truly medicinal about cannabis. Despite the fact that everyone seems to have an opinion about it, reliable information on cannabis is still hard to find. Pharmaceutical researchers, traditionally focusing on isolated active ingredients, have a hard time understanding cannabis in its complex herbal form. 

Clinical trials, performed under strict conditions and regulations, are incapable of studying the unconventional administration forms, the many cannabis varieties and the dosing regimens that experienced users commonly use. And although a wealth of information seems to be available on cannabis through popular websites, discussion forums and magazines, this is often based on single patient stories and assumptions. Opinions and facts may get mixed up when seriously ill patients share their personal experiences with others without the involvement of a medical professional. 

As a result of all this, cannabis seems to be caught in the middle: too herbal for modern allopathic medicine, and yet too potent for herbal or ‘alternative’ medicine. There is a need for balanced information, clearly communicating the therapeutic but also the less desired effects of cannabis use.